Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death | Zendy

Peter R. Kowey | Zendy; Harry J.G.M. Crijns | Zendy; Etienne Aliot | Zendy; Alessandro Capucci | Zendy; Piotr Kułakowski | Zendy; David Radzik | Zendy; DenisClaude Roy | Zendy; Stuart J. Connolly | Zendy; Stefan H. Hohnloser | Zendy

Open Access

Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death

Author(s) -

Peter R. Kowey,

Harry J.G.M. Crijns,

Etienne Aliot,

Alessandro Capucci,

Piotr Kułakowski,

David Radzik,

DenisClaude Roy,

Stuart J. Connolly,

Stefan H. Hohnloser

Publication year - 2011

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.072561

Subject(s) - medicine , ventricular tachycardia , ventricular fibrillation , amiodarone , implantable cardioverter defibrillator , placebo , cardiology , clinical endpoint , defibrillation , ejection fraction , sudden cardiac death , hazard ratio , randomized controlled trial , atrial fibrillation , heart failure , confidence interval , alternative medicine , pathology

Celivarone is a new antiarrhythmic agent developed for the treatment of ventricular arrhythmias. This study investigated the efficacy and safety of celivarone in preventing implantable cardioverter-defibrillator (ICD) interventions or death.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research